Core Viewpoint - Jiahe Meikang has announced an annual performance forecast indicating a projected net loss attributable to shareholders of the listed company ranging from -240 million to -280 million yuan for the year 2025 [1] Financial Performance - The expected net profit excluding non-recurring gains and losses for 2025 is projected to be between -246 million and -286 million yuan [1] - The company is experiencing a decline in revenue due to reduced or delayed fiscal budget support from local governments for public hospitals' medical information construction [1] Market Conditions - The overall economic cycle fluctuations have led to a compression or postponement of procurement demand from hospitals [1] - The implementation of medical insurance cost control reforms has resulted in decreased income for some hospitals, further compressing the demand for medical information construction funded by their own resources [1] Strategic Initiatives - In response to opportunities in the "14th Five-Year" artificial intelligence application market, the company plans to increase investment in product development for data and artificial intelligence businesses in 2025 [1] - This strategic shift is contributing to the company's losses during the reporting period [1]

Core Viewpoint - The company expects its revenue in 2025 to remain flat compared to the previous year, with a significant decline in net profit attributed to increased R&D investments and rising operational costs [1] Financial Performance - The company forecasts a net profit attributable to shareholders of between 8 million and 11.5 million, representing a year-on-year decline of 81.26% to 73.06% [1] - The adjusted net loss is projected to be between 4 million and 2 million, reflecting a year-on-year decrease of 110.38% to 105.19% [1] Cost and Investment - The increase in sales, R&D, and management expenses is approximately 33 million, which has impacted profitability [1] - The company has made significant investments in R&D, contributing to the changes in financial performance [1] Credit and Collections - The company has seen notable improvements in its collection efforts, leading to a reduction in credit impairment losses for two consecutive years [1]

海兰信公告，预计2025年度净利润为4000万元到6000万元，同比增长387.47%到631.20%。2025年度， 公司持续落实"精品战略"，加大自主产品占比，整合供应链体系，拓展供应商渠道，优化采购策略，进 一步降低了采购成本，使得公司整体毛利率水平较去年同期实现了显著提升。同时，"海南省海洋灾害 综合防治能力建设项目（EPC+O）"项目的验收，为公司业绩提供了坚实的保障。 ...

Core Viewpoint - The company expects its revenue in 2025 to remain roughly flat compared to the previous year, with a significant decline in net profit attributed to increased R&D investments and rising operational costs [1] Financial Performance - The company projects a net profit attributable to shareholders of between 8 million and 11.5 million yuan, representing a year-on-year decline of 81.26% to 73.06% [1] - The non-recurring net loss is estimated to be between 4 million and 2 million yuan, reflecting a year-on-year decrease of 110.38% to 105.19% [1] Cost and Investment - The increase in sales, R&D, and management expenses is approximately 33 million yuan year-on-year, driven by heightened R&D investments [1] - Despite the increase in expenses, the company has seen significant improvements in cash collection, with credit impairment losses decreasing for two consecutive years [1]

分析师：张刚 登记编码：S0730511010001 相关报告 zhanggang@ccnew.com 021-50586990 传媒酿酒行业领涨 A 股小幅上行 《市场分析：煤炭有色行业领涨 A 股小幅上 行》 2026-01-28 《市场分析：金融半导体领涨 A 股小幅上 行 》 2026-01-27 《市场分析：金融有色行业领涨 A 股小幅整 ——市场分析 理 》 2026-01-26 联系人： 李智 电话： 0371-65585629 风险提示：海外超预期衰退，影响国内经济复苏进程；国内政 策及经济复苏进度不及预期；宏观经济超预期扰动；政策超预期 变化；国际关系变化带来经济环境变化；海外宏观流动性超预期 收紧；海外波动加剧。 本报告版权属于中原证券股份有限公司 www.ccnew.com 请阅读最后一页各项声明 第1页 / 共7页 地址： 郑州郑东新区商务外环路10号18楼 地址： 上海浦东新区世纪大道 1788 号 T1 座 22 楼 证券研究报告-市场分析 发布日期：2026 年 01 月 29 日 投资要点： ◼ A 股市场综述 周四（01 月 29 日）A 股市场先抑后扬、小幅震荡上行，早盘股 ...

从资金流向上来看，当日软件开发板块主力资金净流入19.32亿元，游资资金净流出14.88亿元，散户资金 净流出4.44亿元。软件开发板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002230 科大讯飞 | | 15.401Z | 12.13% | -9.14亿 | -7.20% | -6.26 Z | -4.93% | | 300033 | 同花顺 | 4.01亿 | 7.67% | -1.32 乙 | -2.53% | -2.69 Z- | -5.14% | | 601360 | 三六零 | 3.62亿 | 7.48% | -1.50 Z | -3.09% | -2.13 Z | -4.39% | | 300253 卫宁健康 | | 2.41 乙 | 8.77% | -4099.49万 | -1.49% | -2.00 Z | -7.28% | | 600588 用友网络 | | 1. ...

Core Viewpoint - The company expects a significant annual loss for 2025, projecting a net profit attributable to shareholders between -90 million to -130 million yuan, and a non-recurring net profit between -102 million to -148 million yuan, indicating a strategic transformation struggle [1] Financial Performance - The projected losses contrast sharply with the previous year's net profit of 8.09 million yuan and a non-recurring net profit of -4.11 million yuan [1] - The anticipated losses are attributed to a contraction in traditional IT solution services, leading to decreased revenue and increased costs [1] Strategic Challenges - The company is facing challenges in its innovative business, which has not met profitability expectations [1] - Increased research and development expenditures are contributing to the financial strain [1] - The current year's financial results are also impacted by the accrual of convertible bond interest and stock incentive expenses, which together affect profits by 44.24 million yuan [1]

兴图新科于2020年1月6日在上交所科创板上市，发行数量为1,840.00万股，发行价格为28.21元/ 股。兴图新科上市的保荐机构（主承销商）为中泰证券股份有限公司，保荐代表人为陈胜可、马闪亮。 兴图新科于上市后第三个交易日（2020年1月8日）盘中创下最高价60.89元，为该股上市以来最高 价。 兴图新科首次公开发行股票募集资金总额为51,906.40万元，募集资金净额46,622.76万元。该公司最 终募集资金净额较原计划多6037.93万元。 兴图新科2019年12月30日披露的招股书显示，公司拟募集资 金40,584.83万元，计划用于基于云联邦架构的军用视频指挥平台升级及产业化项目、研发中心建设项 目、补充流动资金。 中国经济网北京1月29日讯 兴图新科(688081.SH)昨晚披露2025年度业绩预告。经财务部门初步测 算，公司预计2025年度实现归属于母公司所有者的净利润-7,000.00万元到-5,800.00万元，与上年同期 （法定披露数据）相比，亏损将减少1,066.38万元到2,266.38万元，同比亏损收窄13.22%到28.10%。 公司预计2025年度实现归属于母公司所有者的扣除 ...

Core Viewpoint - The data indicates significant capital inflows into various stocks, highlighting investor interest in specific sectors and companies, particularly in cultural, beverage, and technology industries [1][2][3] Group 1: Stock Performance and Capital Inflows - BlueFocus has seen a capital inflow of 2.713 billion, with a price increase of 14.15% [2] - Kweichow Moutai attracted 2.559 billion in capital, reflecting a 6.88% rise [2] - Northern Rare Earth experienced a 7.77% increase with 1.610 billion in inflows [2] - iFlytek recorded a capital inflow of 1.557 billion, with a 6.96% rise [2] - Aerospace Science and Technology saw 1.144 billion in inflows, with a notable increase of 9.98% [2] Group 2: Sector Analysis - The cultural sector, represented by BlueFocus and Zhejiang Wenlian, shows strong investor interest, with inflows of 2.713 billion and 0.850 billion respectively [2][3] - The beverage industry, particularly Kweichow Moutai and Wuliangye, continues to attract significant capital, indicating robust consumer demand [2][3] - The technology sector, including companies like iFlytek and Tianfu Communication, demonstrates growth potential with substantial capital inflows [2][3] Group 3: Additional Notable Stocks - TCL Zhonghuan in the photovoltaic equipment sector attracted 0.651 billion, with a 5.83% increase [2] - Baosteel shares saw inflows of 0.650 billion, reflecting a 2.69% rise [2] - Other notable stocks include Longxin Bochuang and Luzhou Laojiao, with inflows of 0.595 billion and 0.578 billion respectively, indicating diverse investment interests across sectors [3]

Core Viewpoint - The data indicates significant capital inflows into various stocks, highlighting investor interest in specific sectors and companies, with notable amounts flowing into BlueFocus and Kweichow Moutai among others [1][2][3] Group 1: Stock Performance and Capital Inflows - BlueFocus saw a capital inflow of 2.814 billion, with a price increase of 14.59% [2] - Kweichow Moutai experienced a capital inflow of 1.638 billion, with a price increase of 3.72% [2] - iFlytek had a capital inflow of 1.599 billion, with a price increase of 10% [2] - Northern Rare Earth attracted 1.397 billion in capital inflow, with a price increase of 8.34% [2] - Tianfu Communication received 1.090 billion, with a price increase of 5.09% [2] - Zhejiang Wenhu Interconnect had a capital inflow of 0.779 billion, with a price increase of 9.98% [2] - TCL Zhonghuan saw a capital inflow of 0.667 billion, with a price increase of 7.99% [2] - Baosteel received 0.608 billion, with a price increase of 4.23% [3] - Changxin Bochuang attracted 0.558 billion, with a price increase of 7.27% [3] - Jiejia Weichuang had a capital inflow of 0.553 billion, with a price increase of 11.6% [3] - Aerospace Science and Technology received 0.524 billion, with a price increase of 7.13% [3] - Yanshan Technology attracted 0.503 billion, with a price increase of 4.81% [3] - Shenghe Resources had a capital inflow of 0.486 billion, with a price increase of 10% [3] - Tianlong Group saw a capital inflow of 0.483 billion, with a price increase of 18.8% [3] - Kunlun Wanwei received 0.436 billion, with a price increase of 6.93% [3] - Junhai received 0.416 billion, with a price increase of 34.46% [3] - 360 had a capital inflow of 0.407 billion, with a price increase of 4.79% [3] - Xinke Mobile U attracted 0.400 billion, with a price increase of 5.92% [3] - Luzhou Laojiao received 0.395 billion, with a price increase of 5.54% [3]